Abstract:The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in maintaining multiorgan health and homeostasis. Endothelial functions in health include dynamic maintenance of vascular tone, angiogenesis, hemostasis, and the provision of an antioxidant, anti-inflammatory, and antithrombotic interface. Dysfunction of the vascular endothelium presents with impaired endothelium-dependent vasodilation, heightened oxidative stress, chronic inflammation, leukocyte adhesion and hyperpermeability, and endothelial cell senescence. Recent studies have implicated altered endothelial cell metabolism and endothelial-to-mesenchymal transition as new features of endothelial dysfunction. Endothelial dysfunction is regarded as a hallmark of many diverse human panvascular diseases, including atherosclerosis, hypertension, and diabetes. Endothelial dysfunction has also been implicated in severe coronavirus disease 2019. Many clinically used pharmacotherapies, ranging from traditional lipid-lowering drugs, antihypertensive drugs, and antidiabetic drugs to proprotein convertase subtilisin/kexin type 9 inhibitors and interleukin 1β monoclonal antibodies, counter endothelial dysfunction as part of their clinical benefits. The regulation of endothelial dysfunction by noncoding RNAs has provided novel insights into these newly described regulators of endothelial dysfunction, thus yielding potential new therapeutic approaches. Altogether, a better understanding of the versatile (dys)functions of endothelial cells will not only deepen our comprehension of human diseases but also accelerate effective therapeutic drug discovery. In this review, we provide a timely overview of the multiple layers of endothelial function, describe the consequences and mechanisms of endothelial dysfunction, and identify pathways to effective targeted therapies.Significance StatementThe endothelium was initially considered to be a semipermeable biomechanical barrier and gatekeeper of vascular health. In recent decades, a deepened understanding of the biological functions of the endothelium has led to its recognition as a ubiquitous tissue regulating vascular tone, cell behavior, innate immunity, cell-cell interactions, and cell metabolism in the vessel wall. Endothelial dysfunction is the hallmark of cardiovascular, metabolic, and emerging infectious diseases. Pharmacotherapies targeting endothelial dysfunction have potential for treatment of cardiovascular and many other diseases.

Immune and Metabolic Mechanisms of Endothelial Dysfunction

Impaired Endothelium-dependent Vasodilation and Treatment in Essential Hypertension

The Causal Relationship between Endothelin-1 and Hypertension: Focusing on Endothelial Dysfunction, Arterial Stiffness, Vascular Remodeling, and Blood Pressure Regulation

Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

Estrogen-related mechanisms in sex differences of hypertension and target organ damage

Immune mechanisms in the pathophysiology of hypertension

Systemic and Cardiac Microvascular Dysfunction in Hypertension

Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship

Endothelial dysfunction: molecular mechanisms and clinical implications

Inflammation and hypertension: Underlying mechanisms and emerging understandings

Potential Mechanisms and Clinical Implications

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?

Sex, Endothelial Cell Functions, and Peripheral Artery Disease

Immune mechanisms in arterial hypertension. Recent advances

Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature

Inflammatory Mechanisms Contributing to Endothelial Dysfunction

Endothelial dysfunction and angiogenesis impairment in the ageing vasculature

Immune and inflammatory mechanisms in hypertension

Endothelial dysfunction: mechanisms and contribution to diseases

Mechanisms and Consequences of Endothelial Nitric Oxide Synthase Dysfunction in Hypertension